PORTLAND
— Nanotechnology company AcryMed
received clearance from the Food and Drug Administration for
its product, which makes medical devices impervious to
infection-causing bacteria. AcryMed’s SilvaGard
technology can be used to treat just about any medical device
and was adopted by I-Flow Corp., makers of anesthesia delivery
catheters. Jack McMaken, CEO of AcryMed, says his company is in
development talks with several other device makers. SilvaGuard
will help fight the hospital-related infections that strike 2
million U.S. patients every year.
